Advertisement

Molecular Medicine

, Volume 11, Issue 1–12, pp 39–47 | Cite as

The Role of AEBP1 in Sex-Specific Diet-Induced Obesity

  • Lei Zhang
  • Shannon P Reidy
  • Tara E Nicholson
  • Hyun-Jeong Lee
  • Amin Majdalawieh
  • Chris Webber
  • Bruce R Stewart
  • Peter Dolphin
  • Hyo-Sung Ro
Articles

Abstract

Obesity is an important risk factor for heart disease, diabetes, and certain cancers, but the molecular basis for obesity is poorly understood. The transcriptional repressor AEBP1, which functions as a negative regulator of PTEN through a protein-protein interaction, is highly expressed in the stromal compartment of adipose tissues, including proliferative preadipocytes, and its expression is abolished in terminally differentiated, nonproliferative adipocytes. Here we show that transgenic overexpression of AEBP1 during adipogenesis coupled with a high-fat diet (HFD) resulted in massive obesity in female transgenic (AEBP1TG) mice via adipocyte hyperplasia. AEBP1 levels dynamically changed with aging, and HFD induced AEBP1 expression in females. Thus, HFD-fed AEBP1TG females display hyperinduction of AEBP1 and a marked reduction of PTEN level with concomitant hyperactivation of the survival signal in white adipose tissue. Our results suggest that AEBP1 plays a key functional role in in vivo modulation of adiposity via fat-cell proliferation and is involved in a sex-specific susceptibility to diet-induced obesity by the estrogen signaling pathway.

Notes

Acknowledgements

We are indebted to Bradford Lowell and Joel A. Lawitts for their support in this work, which was initiated during H.-S.R.’s sabbatical leave from the Department of Medicine, Division of Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School. This work was supported by grants from the Canadian Diabetes Association, the Heart and Stroke Foundation (Nova Scotia) of Canada (HSFC), the Natural Sciences and Engineering Research Council (NSERC) of Canada, and Canadian Institutes of Health Research (CIHR) to H.S.R. We acknowledge the support of the HSFC Visiting Scientist Award to H.S.R. and the Postdoctoral Fellowship Program of Korea Science & Engineering Foundation (KOSEF) to H.-J.L.

References

  1. 1.
    Flier JS. (2004) Obesity wars: molecular progress confronts an expanding epi demic. Cell 116:337–50.CrossRefGoogle Scholar
  2. 2.
    Reitman ML. (2004) Magic bullets melt fat. Nat. Med. 10:581–2.CrossRefGoogle Scholar
  3. 3.
    Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W. (2004) Reversal of obesity by targeted ablation of adipose tissue. Nat. Med. 10:625–32.CrossRefGoogle Scholar
  4. 4.
    Distel RJ, Ro H-S, Rosen BS, Groves DL, Spiegelman BM. (1987) Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-fos. Cell 49:835–44.CrossRefGoogle Scholar
  5. 5.
    Herrera R, Ro H-S, Robinson GS, Xanthopoulos KG, Spiegelman BM. (1989) A direct role for C/EBP and the AP-1-binding site in gene expression linked to adipocyte differentiation. Mol. Cell. Biol. 9:5331–9.CrossRefGoogle Scholar
  6. 6.
    Ro H.-S., Roncari D.A.K. (1991) The C/EBP-binding region and adjacent sites regulate expression of the adipose P2 gene in human preadipocytes. Mol. Cell. Biol. 11:2303–6.CrossRefGoogle Scholar
  7. 7.
    He G-P, Muise A, Wu-Li A, Ro H-S. (1995) A eukaryotic transcriptional repressor with carboxypeptidase activity. Nature 378:92–6.CrossRefGoogle Scholar
  8. 8.
    Muise AM, Ro H-S. (1999) Enzymic characterization of a novel member of the regulatory B-like carboxypeptidase with transcriptional repression function: stimulation of enzymic activity by its target DNA. Biochem. J. 343:341–5.CrossRefGoogle Scholar
  9. 9.
    Park J-G, Muise A, He G-P, Kim S-W, Ro H-S. (1999) Transcriptional regulation by the gamma5 subunit of a heterotrimeric G protein during adipogenesis. EMBO J. 18:4004–12.CrossRefGoogle Scholar
  10. 10.
    Kim S, Muise A, Lyons PJ, Ro H-S. (2001) Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation. J. Biol. Chem. 276:10199–206.CrossRefGoogle Scholar
  11. 11.
    Lyons PJ, Muise AM, Ro H-S. (2005) MAPK modulates the DNA binding of adipocyte enhancer-binding protein 1. Biochemistry 44:926–31.CrossRefGoogle Scholar
  12. 12.
    Ro H-S, Kim S-W, Wu D, Webber C, Nicholson TE. (2001) Gene structure and expression of the mouse adipocyte enhancer-binding protein. Gene 280: 123–33.CrossRefGoogle Scholar
  13. 13.
    Layne MD et al. (1998) Aortic carboxypeptidase-like protein, a novel protein with discoidin and carboxypeptidase-like domains, is up-regulated during vascular smooth muscle cell differentiation. J. Biol. Chem. 273:15654–60.CrossRefGoogle Scholar
  14. 14.
    Gorbenko O et al. (2004) Identification of a novel binding partners for tumor suppressor PTEN by a yeast two-hybrid approach. Exp. Oncol. 26:15–9.Google Scholar
  15. 15.
    Sulis ML, Parsons R. (2003) PTEN: from pathology to biology. Trends Cell Biol. 13:478–83.CrossRefGoogle Scholar
  16. 16.
    Goberdhan DCI, Wilson C. (2003) PTEN: tumor suppressor, multifunctional growth regulator and more. Human Mol. Genet. 12:R239–48.CrossRefGoogle Scholar
  17. 17.
    Ross SR et al. (1990) A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc. Natl. Acad. Sci. U. S. A. 87:9590–4.CrossRefGoogle Scholar
  18. 18.
    Makowski L et al. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med. 7:699–705.CrossRefGoogle Scholar
  19. 19.
    Kuksis A, Myher JJ, Marai L, Geher K. (1976) Estimation of plasma free fatty acids as the trimethylsilyl (TMS) esters. Anal. Biochem. 70:302–12.CrossRefGoogle Scholar
  20. 20.
    Hirsch J, Gallian E. (1968) Methods for the determination of adipose cell size in man and animals. J. Lipid Res. 9:110–9.PubMedGoogle Scholar
  21. 21.
    He G-P, Kim S, Ro H-S. (1999) Cloning and characterization of a novel zinc finger transcriptional repressor: a direct role of the zinc finger motif in repression. J. Biol. Chem. 274:14678–84.CrossRefGoogle Scholar
  22. 22.
    Prins JB et al. (1997) Tumor necrosis factor-a induces apoptosis of human adipose cells. Diabetes 46:1939–44.CrossRefGoogle Scholar
  23. 23.
    Gagnon A, Dods P, Roustan-Delatour N, Chen C-S, Sorisky A. (2001) Phosphatidylinositol-3,4,5-trisphosphate is required for insulin-like growth factor 1-mediated survival of 3T3-L1 preadipocytes. Endocrinology 142:205–12.CrossRefGoogle Scholar
  24. 24.
    Longo KA, Kennell JA, Ochocinska MJ, Ross SE, Wright WS, MacDougald OA. (2002) Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J. Biol. Chem. 277:38239–44.CrossRefGoogle Scholar
  25. 25.
    Fischer-Posovszky P, Tornqvist H, Debatin KM, Wabitsch M. (2004) Inhibition of death-receptor mediated apoptosis in human adipocytes by the insulin-like growth factor I (IGF-I)/IGF-I receptor autocrine circuit. Endocrinology 145:1849–59.CrossRefGoogle Scholar
  26. 26.
    Van Harmelen V et al. (1998) Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47:913–7.CrossRefGoogle Scholar
  27. 27.
    Okuno A et al. (1998) Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 101:1354–61.CrossRefGoogle Scholar
  28. 28.
    Kubota N et al. (1999) PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell 4:597–609.CrossRefGoogle Scholar
  29. 29.
    Kurlawalla-Martinez C, Stiles B, Wang Y, Devaskar SU, Kahn BB, Wu H. (2005) Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol. Cell. Biol. 25:2498–510.CrossRefGoogle Scholar
  30. 30.
    Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112:1796–808.CrossRefGoogle Scholar
  31. 31.
    Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, Kahn CR. (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell 3:25–38.CrossRefGoogle Scholar
  32. 32.
    DeFronzo RA. (1997) Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. 5:177–269.Google Scholar
  33. 33.
    Abel ED et al. (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:729–33.CrossRefGoogle Scholar
  34. 34.
    Bruning JC et al. (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic sysdrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559–69.CrossRefGoogle Scholar
  35. 35.
    Zisman A et al. (2000) Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 6:924–8.CrossRefGoogle Scholar
  36. 36.
    Guerra C et al. (2001) Brown adipose tissue-specific insulin receptor knockout shows phenotype without insulin resistance. J. Clin. Invest. 108: 1205–13.CrossRefGoogle Scholar
  37. 37.
    Haluzik M et al. (2004) Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 145:3258–64.CrossRefGoogle Scholar
  38. 38.
    Wade GN, Gray JM, Bartness, TJ. (1985) Gonadal influence on adiposity. Int. J. Obes. 9:83–92.PubMedGoogle Scholar
  39. 39.
    Pederson SB, Borglum JD, Eriksen EF, Richelsen B. (1991) Nuclear estradiol binding in rat adipocytes: regional variations and regulatory influences of hormones. Biochim. Biophys. Acta 1093:80–6.CrossRefGoogle Scholar
  40. 40.
    Tchernof A, Calles-Escandon J, Sites CK, Poehlman ET. (1998) Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy. Coron. Artery Dis. 9:503–11.CrossRefGoogle Scholar
  41. 41.
    Pederson SB, Borglum JD, Moller-Pederson T, Richelsen B. (1992) Effects of in vivo estrogen treatment on adipose tissue metabolism and nuclear estrogen receptor binding in isolated rat adipocytes. Mol. Cell. Endocrinol. 85:13–9.CrossRefGoogle Scholar
  42. 42.
    Crandall DL, Busler DE, Novak TJ, Weber RV, Kral JG. (1998) Identification of estrogen receptor β RNA in human breast and abdominal subcutaneous adipose tissue. Biochem. Biophys. Res. Comm. 248:523–6.CrossRefGoogle Scholar
  43. 43.
    Heine PA, Taylor JA, Iwamoti GA, Lubahn DB, Cooke PS. (2000) Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. U. S. A. 97:12729–34.CrossRefGoogle Scholar
  44. 44.
    Naaz A et al. (2002) Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm. Metab. Res. 34:758–63.CrossRefGoogle Scholar
  45. 45.
    Kuiper GG et al. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of the estrogen receptors α and β. Endocrinology 138:863–70.CrossRefGoogle Scholar
  46. 46.
    Cowley SM, Hoare S, Mosselman S, Parker MG. (1997) Estrogen receptors alpha and beta form heterodimers on DNA. J. Biol. Chem. 272:19858–62.CrossRefGoogle Scholar
  47. 47.
    Anderson LA, McTernan PG, Barnett AH, Kumar S. (2001) The effects of androgens and estrogens on pradipocyte proliferation in human adipose tissue: influence of gender and site. J. Clin. Endocrinol. Metab. 86:5045–51.CrossRefGoogle Scholar
  48. 48.
    Roncari DAK, Van RL. (1978) Promotion of human adipocyte precursor replication by 17β-estradiol in culture. J. Clin. Invest. 62:503–8.CrossRefGoogle Scholar
  49. 49.
    Hall JM, McDonnell DP. (1999) The estrogen receptor β isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity, and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140:5566–78.CrossRefGoogle Scholar
  50. 50.
    Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. (2002) Postmenopausal hormone replacement therapy: scientific review. JAMA 288:872–81.CrossRefGoogle Scholar

Copyright information

© Feinstein Institute for Medical Research 2005

Authors and Affiliations

  • Lei Zhang
    • 1
  • Shannon P Reidy
    • 1
  • Tara E Nicholson
    • 1
  • Hyun-Jeong Lee
    • 1
  • Amin Majdalawieh
    • 1
  • Chris Webber
    • 1
  • Bruce R Stewart
    • 1
  • Peter Dolphin
    • 1
  • Hyo-Sung Ro
    • 1
  1. 1.Department of Biochemistry & Molecular Biology, Faculty of MedicineDalhousie UniversityHalifaxCanada

Personalised recommendations